Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) — the peer cohort
As of 2026-10-08 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.
Amneal Pharmaceuticals, Inc. Class A Common Stock ranks 8 of 11 in its cohort on the Closelooknet composite (54/100) — the cohort is led by Halozyme Therapeutics Inc at 74/100.
| Name | Composite | Momentum | Quality | Valuation | Signal | Off 52w high |
|---|---|---|---|---|---|---|
| AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock | 54 | 89 | 58 | 42 | ok | 7.2% |
| ROVI.MC Laboratorios Farmaceuticos ROVI | 61 | 27 | 77 | 52 | warn | 31.8% |
| LNTH Lantheus Holdings Inc | 60 | 68 | 74 | 57 | info | 10.5% |
| KNSA Kiniksa Pharmaceuticals Ltd | 57 | 94 | 59 | 21 | ok | 5.1% |
| GALDY GALDERMA GROUP AG | 54 | 44 | 59 | 28 | info | 15% |
| ALM.MC Almirall S.A. | 53 | 22 | 46 | 68 | warn | 27.1% |
| FAGR.BR Fagron NV | 52 | 43 | 56 | 60 | info | 11.9% |
| HALO Halozyme Therapeutics Inc | 74 | 94 | 94 | 51 | ok | 6% |
| DXCM DexCom Inc | 66 | 83 | 80 | 37 | watch | 9% |
| ONC BeiGene, Ltd. | 64 | 77 | 64 | 32 | info | 9.1% |
| MEDP Medpace Holdings Inc | 63 | 82 | 75 | 30 | ok | 11.1% |
Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.
FAQ · from the current data · as of 2026-10-08
Quick answers
Who are Amneal Pharmaceuticals, Inc. Class A Common Stock's peers in the Closelooknet universe?
The cohort is drawn from shared Closelooknet index membership first, then sector: Laboratorios Farmaceuticos ROVI (ROVI.MC), Lantheus Holdings Inc (LNTH), Kiniksa Pharmaceuticals Ltd (KNSA), GALDERMA GROUP AG (GALDY), Almirall S.A. (ALM.MC), Fagron NV (FAGR.BR), Halozyme Therapeutics Inc (HALO), DexCom Inc (DXCM) and others.
How does AMRX score against its peers?
Amneal Pharmaceuticals, Inc. Class A Common Stock's composite reads 54/100, ranking 8 of 11 in its cohort as of 2026-10-08; the cohort's highest composite is Halozyme Therapeutics Inc at 74/100. Closelooknet scores are research diary readings, not ratings or advice.
Related in the Closelooknet universe
then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- ROVI.MC Laboratorios Farmaceuticos ROVIindustry
- LNTH Lantheus Holdings Incindustry
- KNSA Kiniksa Pharmaceuticals Ltdindustry
- GALDY GALDERMA GROUP AGindustry
- ALM.MC Almirall S.A.industry
- FAGR.BR Fagron NVindustry
- HCM.L HUTCHMED China Ltdindustry
- PRGO Perrigo Company PLCindustry
- TEVA Teva Pharma Industries Ltd ADRindustry
- UTHR United Therapeutics Corporationindustry
- VTRS Viatris Incindustry
- TAK Takeda Pharmaceutical Co Ltd ADRindustry
- BHC.TO Bausch Health Companies Incindustry
- ALKS Alkermes Plcindustry
- ZTS Zoetis Incindustry
- DMP.DE Dermapharm Holding SEindustry
- ELAN Elanco Animal Healthindustry
- NBIX Neurocrine Biosciences Incindustry
- HALO Halozyme Therapeutics Incsector
- DXCM DexCom Incsector